The digital pathology software developer is raising funding that would help it to increase its headcount and support its Aiosyn Mitosis Breast application.

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its algorithm for mitotic figure counting ...

More about cancer biomarker for predicting response to drugs targeting mitotic checkpoint kinases and cell division Genomic instability – an increased tendency for DNA mutations and both structural ...